Primobolan 100mg/ml 10ml Vial by Kim Pharma

Usage

1. Establish baseline bloodwork: before the prep cycle begins — measure testosterone, LH, FSH, haematocrit, and fasting lipid panel to create a reference point for mid-prep comparisons.
2. Draw using a 1ml syringe: for precise volume control: at 100mg/ml, each 0.1ml mark equals exactly 10mg, giving you fine-grained dose control over your twice-weekly injections.
3. Swab the vial septum: with a 70% isopropyl alcohol wipe before every draw; allow 30 seconds to dry before inserting the needle to maintain multi-dose vial sterility throughout the prep period.
4. Inject into rotation sites: — glute, outer quad, or deltoid — rotating locations each session to avoid localised tissue fatigue common during multi-week prep protocols with twice-weekly injections.
5. Log each injection volume and date: in a prep journal alongside weekly weight, body-fat estimates, and subjective conditioning notes; correlate these with mid-cycle bloodwork at weeks 4 and 8 to guide dose adjustments.
6. Store the opened vial: at room temperature (15–25°C), away from direct sunlight and heat sources; avoid refrigeration, which increases oil viscosity and makes accurate dose drawing more difficult during lean-out phases.

Warnings

Frequently asked questions

What dosing protocol do competitive bodybuilders follow with Methenolone Enanthate during contest prep?

Competitive bodybuilders typically structure Methenolone Enanthate use across two prep phases: 300–400mg per week from 12–16 weeks out to protect lean mass under caloric deficit, then 400–600mg per week in the final 8 weeks to maximise conditioning and muscle hardness. Doses are split into two equal injections per week to maintain stable plasma levels throughout the prep window.

When should Methenolone Enanthate be introduced into a competition prep stack?

Most contest prep athletes introduce Methenolone Enanthate at the beginning of the prep phase — typically 14 to 16 weeks before competition — allowing several weeks for plasma concentrations to reach effective steady state before the critical conditioning window begins. Earlier introduction also permits early bloodwork checks to confirm individual response before doses are adjusted upward.

Why do many competitors prefer Methenolone Enanthate over testosterone-based compounds in the final weeks before a show?

Methenolone Enanthate does not aromatise to oestrogen, so it avoids the subcutaneous fluid retention that testosterone-based compounds can cause — a decisive advantage in the final two weeks when competitors are attempting to minimise water between skin and muscle. Its low androgenic burden also reduces the risk of last-minute skin or prostate flares that could distract from peak-week protocols.

How do athletes use a 1ml insulin syringe to dose Kim Pharma Primobolan 100mg/ml accurately during prep?

With Kim Pharma's 100mg/ml formulation, each 0.5ml mark on a standard 1ml insulin syringe equals exactly 50mg of Methenolone Enanthate. A 200mg injection requires drawing to the 2ml mark on a standard syringe, or 0.2ml on a high-precision insulin syringe. The 100mg/ml oil solution draws smoothly through a 25–27 gauge needle, which is appropriate for lean glute or deltoid injection sites common in prep athletes.

Does Kim Pharma Primobolan 100mg/ml need refrigeration after the vial is opened, and how long is it stable?

Once punctured, Kim Pharma's 10ml vial should be stored at room temperature away from direct light and heat — refrigeration of oil-based injectables is not required and can increase solution viscosity, making accurate drawing harder. The vial stopper is designed for repeated puncture; using a fresh sterile needle for each draw and swabbing the septum with an alcohol wipe maintains sterility. A 10ml vial at 400mg per week sustains ten weeks of prep from a single unit. (2) angle_used

Manufacturer

Kim Pharma's GMP and ISO compliance framework for its injectable anabolic line is built around a dual-layer verification model: internal batch certification followed by independent third-party analytical confirmation. ISO 9001-aligned quality management systems govern documentation, deviation handling, and change-control procedures across all product lines, while GMP principles specific to sterile injectables dictate environmental standards, personnel hygiene protocols, and in-process testing frequency. For Primobolan 100mg/ml specifically, each manufactured batch is subjected to HPLC potency analysis — the pharmacopoeially recognised method for confirming active-ingredient concentration in oil-based parenteral formulations — and to LAL endotoxin testing before a batch release decision is made. Certificate of Analysis documents generated at release are retained as permanent batch records, available to support regulatory enquiries or buyer verification requests. Kim Pharma's quality posture prioritises verifiable accountability at every production stage rather than relying on label claims alone.